We are live on ! Find out more
CRB

Chad R. Baker Portfolio holdings

AUM $620M
1-Year Est. Return 42.67%
This Fund
S&P 500
This Quarter Est. Return
+2.52%
1 Year Est. Return
+42.67%
3 Year Est. Return
+108.31%
5 Year Est. Return
+132.07%
10 Year Est. Return
+563.15%
AUM
$511M
AUM Growth
+$1.79M
Cap. Flow
+$945K
Cap. Flow %
0.18%
Top 10 Hldgs %
46.76%
Holding
51
New
1
Increased
3
Reduced
11
Closed
1

Top Buys

Rank Stock Value
1
CRM icon
Salesforce
CRM
+$2.81M
2
ULS icon
UL Solutions
ULS
+$2.77M
3
RELX icon
RELX
RELX
+$2.61M
4
ALC icon
Alcon
ALC
+$29.3K

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$4.71M
2
APTV icon
Aptiv
APTV
+$1.07M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$525K
4
PFE icon
Pfizer
PFE
+$325K
5
CRSP icon
CRISPR Therapeutics
CRSP
+$287K

Sector Composition

Rank Sector Weight
1 Technology 31.94%
2 Industrials 19.07%
3 Healthcare 15.81%
4 Consumer Discretionary 13.29%
5 Communication Services 10.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALC icon
26
Alcon
ALC
$34.8B
$7.63M 1.49%
89,850
+325
+0.4% +$29.3K
TJX icon
27
TJX Companies
TJX
$149B
$7.53M 1.47%
62,340
– –
NYT icon
28
New York Times
NYT
$11B
$7.46M 1.46%
143,325
– –
LOW icon
29
Lowe's Companies
LOW
$117B
$6.94M 1.36%
28,100
– –
SYK icon
30
Stryker
SYK
$127B
$6.88M 1.35%
19,095
– –
HD icon
31
Home Depot
HD
$329B
$6.86M 1.34%
17,635
– –
ULS icon
32
UL Solutions
ULS
$15B
$5.6M 1.1%
112,300
+53,500
+91% +$2.77M
RELX icon
33
RELX
RELX
$63.6B
$5.11M 1%
112,450
+55,675
+98% +$2.61M
CL icon
34
Colgate-Palmolive
CL
$72.3B
$4.65M 0.91%
51,200
– –
RTX icon
35
RTX Corp
RTX
$285B
$4.44M 0.87%
38,348
– –
GOOG icon
36
Alphabet (Google) Class C
GOOG
$4.19T
$4.21M 0.82%
22,100
– –
ZTS icon
37
Zoetis
ZTS
$32B
$4.04M 0.79%
24,818
– –
ADBE icon
38
Adobe
ADBE
$116B
$4M 0.78%
9,000
– –
VRTX icon
39
Vertex Pharmaceuticals
VRTX
$137B
$3.92M 0.77%
9,740
– –
CRSP icon
40
CRISPR Therapeutics
CRSP
$5.58B
$3.67M 0.72%
93,205
-6,075
-6% -$287K
CSX icon
41
CSX Corp
CSX
$95B
$3.29M 0.64%
102,000
– –
CRM icon
42
Salesforce
CRM
$211B
$2.94M 0.58%
+8,790
New +$2.81M
MRK icon
43
Merck
MRK
$366B
$2.04M 0.4%
20,550
-1,150
-5% -$119K
XOM icon
44
ExxonMobil
XOM
$644B
$1.76M 0.35%
16,400
– –
CI icon
45
Cigna
CI
$73.7B
$1.61M 0.32%
5,841
– –
NVDA icon
46
NVIDIA
NVDA
$5.25T
$1.33M 0.26%
9,870
-630
-6% -$86.8K
MKC icon
47
McCormick & Company Non-Voting
MKC
$14.9B
$1.19M 0.23%
15,625
– –
BDX icon
48
Becton Dickinson
BDX
$51.6B
$893K 0.17%
3,935
-450
-10% -$104K
NVO
49
Novo Nordisk
NVO
$202B
$444K 0.09%
5,160
-20
-0.4% -$2.16K
PFE icon
50
Pfizer
PFE
$159B
$332K 0.06%
12,500
-12,000
-49% -$325K
1
2
3

Similar funds

PLU
Performa Ltd (US) Charleston, South Carolina $620M AUM 19.43% 1-Year Est. Return
RR
Robotti Robert $620M AUM 55.18% 1-Year Est. Return
TAIM
Te Ahumairangi Investment Management Wellington, New Zealand $620M AUM 14.43% 1-Year Est. Return
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $620M AUM 14.15% 1-Year Est. Return
GPWA
Great Point Wealth Advisors Boston, Massachusetts $619M AUM 14.72% 1-Year Est. Return
MAC
Mason & Associates (California) Los Angeles, California $619M AUM 29.44% 1-Year Est. Return
BT
Brandywine Trust Hockessin, Delaware $621M AUM 15.59% 1-Year Est. Return
IC
Intel Corp Santa Clara, California $621M AUM 34.06% 1-Year Est. Return

Chad R. Baker's Q4 2024 Portfolio in Review

As of Q4 2024, Chad R. Baker held 51 positions worth $511M, up 0.35% from $509M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Trading was light in Q4 2024: portfolio turnover was 3.9%. Chad R. Baker opened 1 new position and exited 1, leaving the 51-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 32% a quarter earlier, followed by Industrials and Healthcare.

  • Chad R. Baker's largest Q4 2024 buy was Salesforce: 8,790 shares worth $2.94M.
  • Chad R. Baker added most to UL Solutions in Q4 2024, an estimated $2.77M increase.
  • Chad R. Baker's biggest Q4 2024 reduction was Apple, cutting an estimated $4.71M.
  • Chad R. Baker fully exited Aptiv in Q4 2024, selling an estimated $1.07M.
  • Chad R. Baker's ten largest holdings make up 47% of its $511M portfolio in Q4 2024.
  • Chad R. Baker opened 1 new position and closed 1 in Q4 2024.
  • Chad R. Baker's portfolio value rose 0.35% quarter-over-quarter to $511M.

Based on Chad R. Baker's 13F filing for Q4 2024, filed 15 Jan 2025.